Depakote is a Oral Tablet, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Remedyrepack Inc.. The primary component is Divalproex Sodium.
Product ID | 70518-1454_774aba77-e6dc-0e0a-e053-2991aa0a8083 |
NDC | 70518-1454 |
Product Type | Human Prescription Drug |
Proprietary Name | Depakote |
Generic Name | Divalproex Sodium |
Dosage Form | Tablet, Delayed Release |
Route of Administration | ORAL |
Marketing Start Date | 2018-10-02 |
Marketing Category | NDA / NDA |
Application Number | NDA018723 |
Labeler Name | REMEDYREPACK INC. |
Substance Name | DIVALPROEX SODIUM |
Active Ingredient Strength | 250 mg/1 |
Pharm Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2018-10-02 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA018723 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2018-10-02 |
Ingredient | Strength |
---|---|
DIVALPROEX SODIUM | 250 mg/1 |
SPL SET ID: | 586c2dfc-6852-44a0-b886-6300c1abb276 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0074-3826 | Depakote | Divalproex Sodium |
0074-6114 | Depakote | Divalproex Sodium |
0074-6212 | Depakote | Divalproex Sodium |
0074-6214 | Depakote | Divalproex Sodium |
0074-6215 | Depakote | Divalproex Sodium |
0074-7126 | Depakote | Divalproex Sodium |
70518-1456 | Depakote | Depakote |
70518-1454 | Depakote | Depakote |
21695-359 | Depakote | Depakote |
21695-163 | Depakote | Depakote |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
DEPAKOTE 75295484 2197507 Dead/Cancelled |
SANOFI-AVENTIS 1997-05-21 |
DEPAKOTE 73383028 1377834 Live/Registered |
SANOFI 1982-09-01 |